Clinical Trials Directory

Trials / Sponsors / GRIN Therapeutics, Inc.

GRIN Therapeutics, Inc.

Industry · 6 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 1 Open-Label Study of Radiprodil Pharmacokinetics, Safety, and Tolerability in Hepatically Impaired Part
Hepatic Impairment
Phase 12026-03-03
RecruitingBeeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN-related Neurodevelopmental Disorder
Phase 32026-01-05
CompletedPhase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered D
Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders
Phase 12025-05-20
TerminatedStudy to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itrac
Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders
Phase 12025-05-08
Active Not RecruitingAstroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavi
Tuberous Sclerosis Complex, Focal Cortical Dysplasia
Phase 1 / Phase 22024-07-10
Active Not RecruitingHoneycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
GRIN-related Disorders
Phase 12023-03-07